PeptideX Editorial
Research & Editorial Team, PeptiDex
The PeptideX Editorial Team is a cross-disciplinary group of researchers, scientists, and medical writers specializing in peptide pharmacology, clinical literature review, and regulatory analysis. Every article published under the editorial byline undergoes multi-stage fact-checking against PubMed-indexed sources, ClinicalTrials.gov registries, and official FDA announcements before publication. The team collectively holds advanced degrees in biochemistry, molecular biology, pharmaceutical sciences, and science communication. Our editorial process follows the same peer-review principles used in academic publishing — including blinded review, citation verification, and mandatory conflict-of-interest disclosure — to ensure the highest standard of accuracy across all compound profiles, comparison guides, and educational content.
Areas of Expertise
Published Articles (17)
Tesamorelin: What Sets It Apart from Every Other Growth Hormone Peptide
A deep-dive comparison of Tesamorelin vs Sermorelin, CJC-1295, Ipamorelin, and MK-677. Covers FDA approval, visceral fat specificity, clinical evidence, and who Tesamorelin is actually best suited for.
Peptide Stacking in 2026: Why Combination Protocols Are Redefining Results
A deep dive into peptide stacking protocols — the Wolverine stack (BPC-157 & TB-500), growth hormone synergy (CJC-1295 & Ipamorelin), longevity and cognitive stacks, and how to combine compounds effectively.
The 2026 FDA Peptide Reclassification: What It Means for Patients, Providers, and the Future of Peptide Therapy
A comprehensive analysis of the 2026 FDA peptide reclassification — which 14 peptides are returning to Category 1, what it means for patients and providers, and how to navigate peptide therapy safely.
Semaglutide vs Tirzepatide: Complete Research Comparison
A head-to-head comparison of semaglutide and tirzepatide — mechanisms, clinical trial data, weight loss efficacy, side effect profiles, and which GLP-1 performs better.
Retatrutide: The Triple-Agonist Peptide Explained
A comprehensive research guide to retatrutide — the first GLP-1/GIP/glucagon triple receptor agonist, its Phase 3 trial status, and what it means for the future of metabolic medicine.
Best Peptides for Muscle Growth: Research-Backed Guide
A research-backed comparison of the best peptides for muscle growth including CJC-1295, Ipamorelin, MK-677, Follistatin-344, and IGF-1 LR3.
MK-677 vs Ipamorelin: Which GH Secretagogue Is Better?
A research-backed comparison of MK-677 (ibutamoren) vs ipamorelin — oral vs injectable GH secretagogues compared on mechanism, side effects, and stacking.
CJC-1295 vs Sermorelin: GHRH Analog Comparison
A research-backed comparison of CJC-1295 and Sermorelin — two GHRH analogs for growth hormone optimization. DAC vs no-DAC, dosing, and clinical outcomes.
Peptide Stacking 101: How to Combine Peptides Safely
A research-backed guide to peptide stacking — principles of safe combination, popular stacks for recovery, body composition, and longevity, timing, and contraindications.
MOTS-c: The Mitochondrial Peptide for Energy & Metabolism
A deep dive into MOTS-c — the mitochondrial-derived peptide that mimics exercise, activates AMPK, and shows remarkable potential for metabolic regulation and longevity.
Oral Peptides vs Injectable Peptides: What You Need to Know
A research-backed comparison of oral vs injectable peptide delivery — bioavailability, SNAC technology, orforglipron, and the future of oral peptide formulations.
14 Peptides Are Going Legal Again in 2026: What the FDA Reclassification Means
The FDA is reclassifying 14 restricted peptides from Category 2 back to Category 1. What it means for patients, clinics, and the future of peptide therapy.
The Oral Peptide Revolution Has Arrived — And It Changes Everything
An independent analysis of the recent FDA approvals for oral GLP-1 and small-molecule peptide therapeutics, and what they mean for the future of longevity and weight loss.
GHK-Cu: The Breakout Peptide of 2026
An independent analysis of GHK-Cu, the copper tripeptide seeing a 1,000% surge in anti-aging, longevity, and skin regeneration research in 2026.
Best Peptides for Fat Loss: A Research Review
Comparing GLP-1 agonists, AOD-9604, and MOTS-c across clinical trials to determine the most effective peptide pathways for lipid oxidation.
Ipamorelin vs CJC-1295: Stack Comparison Guide
Understanding the synergistic GHRP and GHRH relationship that maximizes endogenous growth hormone pulses without cortisol spikes.
Are Research Peptides Legal? A Country-by-Country Guide
Navigating the complex regulatory landscape of purchasing, owning, and researching peptides across North America, Europe, and Australia.
Learn more about our editorial standards and the full PeptiDex team.
Meet the Full TeamPeptiDex is an independent educational platform. Author credentials are self-reported and verified internally. Nothing on this page constitutes medical advice. All content is for research and educational purposes only.